 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Intellia Therapeutics Inc. (NTLA)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-03-06 Purchase | 2019-03-12 4:38 pm | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW VP | 7,500 | $15.72 | $117,875 | 7,500 (Direct) | View |
| 2018-07-16 Sale | 2018-07-18 08:40 am | Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director | 6,686 | $31.17 | $208,397 | 0 (Indirect) | View |
| 2018-06-19 Sale | 2018-06-20 12:03 pm | Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director | 6,686 | $27.96 | $186,908 | 0 (Indirect) | View |
| 2018-05-16 Sale | 2018-05-17 10:47 am | Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director | 6,686 | $25.04 | $167,389 | 0 (Indirect) | View |
| 2018-05-14 Sale | 2018-05-15 8:43 pm | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 8,400 | $24 | $201,600 | 0 (Direct Indirect) | View |
| 2018-03-20 Sale | 2018-03-22 1:43 pm | Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director | 39,245 | $23.87 | $936,743 | 0 (Indirect) | View |
| 2018-01-29 Sale | 2018-01-30 5:28 pm | Intellia Therapeutics Inc. | NTLA | Caribou Biosciences Inc. 10% Owner | 550,645 | $26.78 | $14,746,273 | 3,994,355 (Indirect) | View |
| 2017-12-12 Sale | 2017-12-14 12:19 pm | Intellia Therapeutics Inc. | NTLA | Novartis Institutes for BioMedical Research Inc. NOVARTIS AG 10% Owner | 1,523,000 | $18.3 | $27,870,899 | 4,129,903 (Direct) | View |
| 2017-12-06 Sale | 2017-12-08 5:27 pm | Intellia Therapeutics Inc. | NTLA | Bermingham Nessan CEO | 336,783 | $20.78 | $7,000,019 | 458,250 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-08-01 Option Award | 2019-08-02 4:15 pm | N/A 2029-07-31 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW COO | 55,000 | $18.09 | 55,000 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-04 4:16 pm | N/A 2029-05-27 | Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP Chief Scientific Officer | 150,000 | $14.25 | 150,000 (Direct) | View |
| 2019-05-21 Option Award | 2019-05-22 4:36 pm | N/A 2029-05-20 | Intellia Therapeutics Inc. | NTLA | Verwiel Frank Director | 19,000 | $15.78 | 19,000 (Direct) | View |
| 2019-05-21 Option Award | 2019-05-22 4:35 pm | N/A 2029-05-20 | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $15.78 | 19,000 (Direct) | View |
| 2019-05-21 Option Award | 2019-05-22 4:34 pm | N/A 2029-05-20 | Intellia Therapeutics Inc. | NTLA | GOODMAN JESSE Director | 19,000 | $15.78 | 19,000 (Direct) | View |
| 2019-05-21 Option Award | 2019-05-22 4:34 pm | N/A 2029-05-20 | Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director | 19,000 | $15.78 | 19,000 (Direct) | View |
| 2019-05-21 Option Award | 2019-05-22 4:33 pm | N/A 2029-05-20 | Intellia Therapeutics Inc. | NTLA | DORSA CAROLINE Director | 19,000 | $15.78 | 19,000 (Direct) | View |
| 2019-05-21 Option Award | 2019-05-22 4:32 pm | N/A 2029-05-20 | Intellia Therapeutics Inc. | NTLA | Cohen Fred E Director | 19,000 | $15.78 | 19,000 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-05 4:36 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | Cohen Fred E Director | 10,000 | $16.89 | 10,000 (Direct) | View |
| 2019-01-23 Option Award | 2019-01-24 5:31 pm | N/A 2029-01-22 | Intellia Therapeutics Inc. | NTLA | Cohen Fred E Director | 38,000 | $13.78 | 38,000 (Direct) | View |
| 2018-12-18 Option Award | 2018-12-20 4:25 pm | N/A 2028-12-17 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 71,000 | $14.58 | 71,000 (Direct) | View |
| 2018-12-18 Option Award | 2018-12-20 4:23 pm | N/A 2028-12-17 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW VP | 81,000 | $14.58 | 81,000 (Direct) | View |
| 2018-12-18 Option Award | 2018-12-20 4:21 pm | N/A 2028-12-17 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 240,000 | $14.58 | 240,000 (Direct) | View |
| 2018-12-18 Option Award | 2018-12-20 4:16 pm | N/A 2028-12-17 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn CFO | 17,750 | $14.58 | 17,750 (Direct) | View |
| 2018-11-01 Option Award | 2018-12-20 4:15 pm | N/A 2028-10-31 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn See Remarks | 90,000 | $19.27 | 90,000 (Direct) | View |
| 2018-11-01 Option Award | 2018-11-01 6:37 pm | N/A 2018-10-31 | Intellia Therapeutics Inc. | NTLA | Goddard Glenn SEE REMARKS | 90,000 | $19.27 | 90,000 (Direct) | View |
| 2018-10-29 Option Award | 2018-10-31 5:58 pm | N/A 2018-10-28 | Intellia Therapeutics Inc. | NTLA | GOODMAN JESSE Director | 38,000 | $18.52 | 38,000 (Direct) | View |
| 2018-05-17 Option Award | 2018-05-21 12:59 pm | N/A 2028-05-16 | Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director | 19,000 | $25.98 | 19,000 (Direct) | View |
| 2018-05-17 Option Award | 2018-05-21 12:56 pm | N/A 2028-05-16 | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $25.98 | 19,000 (Direct) | View |
| 2018-05-17 Option Award | 2018-05-21 12:54 pm | N/A 2028-05-16 | Intellia Therapeutics Inc. | NTLA | DORSA CAROLINE Director | 19,000 | $25.98 | 19,000 (Direct) | View |
| 2018-05-17 Option Award | 2018-05-21 12:51 pm | N/A 2028-05-16 | Intellia Therapeutics Inc. | NTLA | Verwiel Frank Director | 19,000 | $25.98 | 19,000 (Direct) | View |
| 2018-05-01 Option Award | 2018-05-02 4:35 pm | N/A 2028-04-30 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW VP | 23,500 | $20.56 | 23,500 (Direct) | View |
| 2018-03-28 Exercise | 2018-03-30 10:20 am | N/A N/A | Intellia Therapeutics Inc. | NTLA | Bell Graeme CFO | 8,000 | $13.48 | 202,000 (Direct) | View |
| 2018-03-28 Exercise | 2018-03-30 10:20 am | N/A 2027-01-02 | Intellia Therapeutics Inc. | NTLA | Bell Graeme CFO | 8,000 | $13.48 | 202,000 (Direct) | View |
| 2018-03-23 Option Award | 2018-03-26 5:12 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | DORSA CAROLINE Director | 410 | $24.05 | 5,410 (Direct) | View |
| 2018-01-25 Option Award | 2018-01-29 3:32 pm | N/A 2028-01-24 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. CEO | 220,000 | $22.78 | 220,000 (Direct) | View |
| 2018-01-25 Option Award | 2018-01-29 3:31 pm | N/A 2028-01-24 | Intellia Therapeutics Inc. | NTLA | Bell Graeme CFO | 25,000 | $22.78 | 25,000 (Direct) | View |
| 2018-01-25 Option Award | 2018-01-29 3:30 pm | N/A 2028-01-24 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 25,000 | $22.78 | 25,000 (Direct) | View |
| 2017-12-12 Option Award | 2017-12-14 4:08 pm | N/A 2027-12-11 | Intellia Therapeutics Inc. | NTLA | Rivera Jose E VP | 72,500 | $18.3 | 72,500 (Direct) | View |
| 2017-12-12 Option Award | 2017-12-14 4:08 pm | N/A 2027-12-11 | Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. VP | 72,500 | $18.3 | 72,500 (Direct) | View |
| 2017-12-12 Option Award | 2017-12-14 4:07 pm | N/A 2027-12-11 | Intellia Therapeutics Inc. | NTLA | Bermingham Nessan CEO | 292,500 | $18.3 | 292,500 (Direct) | View |
| 2017-12-12 Option Award | 2017-12-14 4:06 pm | N/A 2027-12-11 | Intellia Therapeutics Inc. | NTLA | Bell Graeme CFO | 72,500 | $18.3 | 72,500 (Direct) | View |